JP2024533263A5 - - Google Patents
Info
- Publication number
- JP2024533263A5 JP2024533263A5 JP2024514641A JP2024514641A JP2024533263A5 JP 2024533263 A5 JP2024533263 A5 JP 2024533263A5 JP 2024514641 A JP2024514641 A JP 2024514641A JP 2024514641 A JP2024514641 A JP 2024514641A JP 2024533263 A5 JP2024533263 A5 JP 2024533263A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrrolo
- pyrimidine
- chloro
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163260942P | 2021-09-07 | 2021-09-07 | |
| US63/260,942 | 2021-09-07 | ||
| PCT/US2022/075966 WO2023039368A1 (en) | 2021-09-07 | 2022-09-06 | Methods for treating neurogenerative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533263A JP2024533263A (ja) | 2024-09-12 |
| JP2024533263A5 true JP2024533263A5 (https=) | 2025-09-17 |
Family
ID=85506882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514641A Pending JP2024533263A (ja) | 2021-09-07 | 2022-09-06 | 神経原性疾患を処置するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240382491A1 (https=) |
| EP (1) | EP4398986A4 (https=) |
| JP (1) | JP2024533263A (https=) |
| CN (1) | CN118251225A (https=) |
| CA (1) | CA3230996A1 (https=) |
| MX (1) | MX2024002886A (https=) |
| WO (1) | WO2023039368A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202108519TA (en) | 2019-02-13 | 2021-09-29 | Ptc Therapeutics Inc | Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia |
| WO2020167624A1 (en) | 2019-02-13 | 2020-08-20 | Ptc Therapeutics, Inc. | Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012012656A2 (en) * | 2010-07-21 | 2012-01-26 | University Of South Florida | Materials and methods for treating neurodegenerative diseases |
| EP2867236B1 (en) * | 2012-06-29 | 2017-06-14 | Pfizer Inc | Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors |
| CA2973949C (en) * | 2015-01-16 | 2023-07-11 | The General Hospital Corporation | Compounds for improving mrna splicing |
| WO2020167624A1 (en) | 2019-02-13 | 2020-08-20 | Ptc Therapeutics, Inc. | Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia |
-
2022
- 2022-09-06 CN CN202280074005.1A patent/CN118251225A/zh active Pending
- 2022-09-06 WO PCT/US2022/075966 patent/WO2023039368A1/en not_active Ceased
- 2022-09-06 US US18/689,624 patent/US20240382491A1/en active Pending
- 2022-09-06 MX MX2024002886A patent/MX2024002886A/es unknown
- 2022-09-06 EP EP22868236.5A patent/EP4398986A4/en active Pending
- 2022-09-06 JP JP2024514641A patent/JP2024533263A/ja active Pending
- 2022-09-06 CA CA3230996A patent/CA3230996A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10676479B2 (en) | Imidazolepyridine compounds and uses thereof | |
| AU2016328619B2 (en) | Heterocyclic compounds and uses thereof | |
| US9695200B2 (en) | Heterocyclic ITK inhibitors for treating inflammation and cancer | |
| US7666879B2 (en) | Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors | |
| TWI694076B (zh) | 三唑并嘧啶化合物及其用途 | |
| JP2024533263A5 (https=) | ||
| CN101594871A (zh) | 吡咯并嘧啶化合物及其用途 | |
| MX2014006409A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| EP3472161B1 (en) | Triazolopyridine compounds and uses thereof | |
| TWI589574B (zh) | 飢餓素ｏ－醯基轉移酶抑制劑 | |
| HK1258996A1 (zh) | 新型fyn激酶抑制剂的方法、组合物以及用途 | |
| US12286420B2 (en) | EAAT2 activators and methods of using thereof | |
| AU2018453188B2 (en) | Novel hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | |
| JP2017525721A (ja) | 認知欠損または認知障害に伴って進行する神経障害のおよび神経変性疾患の処置および予防のための製品 | |
| JP2022546414A5 (https=) | ||
| JP2019509272A (ja) | 脊髄性筋萎縮症の治療のための併用療法 | |
| JP2017528515A5 (https=) | ||
| JP2024533264A5 (https=) | ||
| CN120040441A (zh) | 用于治疗癌症的组合物和方法 | |
| JP5770181B2 (ja) | 抗結核剤としてのスペクチナミド類 | |
| JP2023506488A5 (https=) | ||
| US12612372B2 (en) | Oxopyridazinyl-phenyl-carbonohydrazonoyl dicyanide compound and use thereof | |
| CN101484457A (zh) | 作为用于治疗增殖病症的蛋白激酶PLK1抑制剂的4,5-二氢-[1,2,4]三唑并[4,3-f]蝶啶 | |
| JP2017523211A (ja) | 新規化合物およびそれを用いてｉｌ−１ｒ媒介性の疾患または障害を処置するかまたは寛解させる方法 | |
| AU2007223865A1 (en) | Use of pyrazolo[1,5A]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders |